If you've been investing long enough, you may have heard that historically September is not a great month for stock market returns. While there's some data to back this up, I prefer to think of September as a buying opportunity.

In that spirit, I'm turning my attention to three healthcare stocks I think are strong buys for September and beyond. After recent earnings results, each has given me renewed faith in their long-term potential.

Moderna (NASDAQ: MRNA) has become a household name due to its successful coronavirus vaccine. Because of its rise in name recognition, it's easy to forget that this vaccine is Moderna's only commercially available product. The long-term investing thesis needs to be based on the application of the mRNA technology in other areas, but some revenue from the COVID-19 vaccine can be expected for the near term.

Continue reading

Source Fool.com